Anna Mannfalk’s advocacy for enhanced screening and lifestyle interventions highlights a pivotal shift in prioritising diabetes prevention as a measurable and actionable public health goal in Region Skåne, with implications for wider policy and economic savings.
Anna Mannfalk’s support for more systematic diabetes prevention in Region Skåne is a welcome sign that the issue is finally being treated as a public health priority rather than a side concern. In a debate piece in Kristianstadsbladet, the chair of the regional health and medical care board backed screening of higher-risk patients, stronger lifestyle advice and more transparent reporting on how many people are actually offered blood glucose tests.
That approach is well supported by research. A recent systematic review and meta-analysis found that lifestyle interventions delivered through primary care can reduce the incidence of type 2 diabetes among people with prediabetes or at risk of the disease. Another review concluded that while screening tests have limits, they can still be valuable when they lead to interventions that prevent or delay the onset of type 2 diabetes. In other words, screening on its own is not the answer, but screening linked to action can be.
The need for that action is especially clear in southern Sweden. The debate article says about 171,000 people in Skåne are living with type 2 diabetes, many without knowing it, and that the regional cost is about 4.5 billion kronor a year. Research on Malmö has pointed to similarly heavy economic consequences, with excess primary care costs alone estimated at €12.7 million, underlining how much prevention could save as well as how much it could improve lives. A 2026 review in BMJ Nutrition, Prevention & Health also suggests that certain biochemical tests may help identify those at greatest risk more accurately, while a scoping review found that continuous and flash glucose monitoring may improve glucose control and health behaviours in adults at risk. Even so, a U.S. Preventive Services Task Force review found no mortality benefit from screening alone, reinforcing the point that any programme must be built around follow-up, support and sustained care.
For Region Skåne, the test is not whether diabetes prevention sounds sensible. It is whether the region turns promises into a measurable system with clear targets, consistent offers of testing and public reporting that shows whether the policy is reaching the people who need it most.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
